Cingulate Inc. Ttl Prevsly Pd Amt
Cingulate Inc. (CING) had Ttl Prevsly Pd Amt of $0 as of 2026-04-14, per its S-3 filed 2026-04-14.
Financial Statements › Notes
ffd:TtlPrevslyPdAmt · last filed 2026-04-14
- 2026-04-14: Ttl Prevsly Pd Amt $0.00.
| Period end | Ttl Prevsly Pd Amt |
|---|---|
| 2026-04-14 | $0.00 S-3 · filed 2026-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |